Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nateglinide vs Glibenclamide on Renal Hemodynamics
NCT00238472Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of nateglinide in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started May 2003; status: completed.
02
Drugs
nateglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00238472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238472.